# Brain Ketone Bodies in Health, Evolution and Disease

**Authors:** Pierre Bougnères

PMC · DOI: 10.3390/cells15040382 · 2026-02-23

## TL;DR

Ketone bodies are unique energy sources for the brain that can increase during fasting and may help the brain adapt to food shortages and diseases like Alzheimer's.

## Contribution

The paper highlights the evolutionary and metabolic significance of ketone bodies and their potential therapeutic use in neurodegenerative diseases.

## Key findings

- Ketone bodies can increase twenty-fold during fasting and provide energy to the brain.
- Ketone bodies can modify proteins like histones, possibly acting as epigenetic messengers.
- Ketogenic diets may help treat diseases like Alzheimer's by improving brain energy metabolism.

## Abstract

Ketone bodies (KBs) are the only energy substrates oxidized by the brain, whose concentration in the circulation can greatly increase when a physiological situation requires it. For example, when an adult human fasts for two days, circulating KBs rise twenty-fold from ~0.1 to ~2 mM. As a fuel, KBs provide the brain with acetyl-CoA that produces ATP or glutamate, notably in certain brain regions. Remarkably, KBs activate the expression of their own cerebral transporters and KB-utilizing enzymes so that circulating levels determine cerebral utilization of KBs. Throughout evolution, the energetic role of KBs has been crucial for the metabolic homeostasis of humans endowed with a large brain and facing unpredictable periods of food shortage. Paradoxically, the brain of modern, regularly fed humans whose ordinary blood KBs are ~0.1 mM, has access to much fewer circulating sources of energy than that of their distant ancestors. KBs can modify certain proteins post-translationally, for example, histones through lysine-butyrylation. KBs could act as short- or long-term epigenetic messengers. These properties of KBs might allow a fetus to directly sense maternal starvation and adapt their cerebral metabolism to this situation, possibly preparing for nutritional constraints in extra-uterine life. KB transcriptional and epigenetic properties could also enable the postnatal organism to retain a molecular memory of its own starvation episodes. No other energy substrate, such as glucose or lactate, has such capacities. Medicine turned its attention to KBs a century ago. Indeed, KBs are the only energy substrates whose circulating levels can be increased, and nutritional interventions can alter them under free-living conditions. This property opens broad prospects for ketogenic diets (KDs) to prevent or rescue neurodegenerative diseases characterized by glucose hypometabolism, notably Alzheimer’s disease (AD). However, KDs have not yet found real medical applications, for reasons that are discussed.

## Linked entities

- **Chemicals:** acetyl-CoA (PubChem CID 444493), ATP (PubChem CID 5957), glutamate (PubChem CID 611), glucose (PubChem CID 5793), lactate (PubChem CID 61503)
- **Diseases:** Alzheimer’s disease (MONDO:0004975)

## Full-text entities

- **Genes:** GLP1R (glucagon like peptide 1 receptor) [NCBI Gene 2740] {aka GLP-1, GLP-1-R, GLP-1R}, BDH1 (3-hydroxybutyrate dehydrogenase 1) [NCBI Gene 622] {aka BDH, SDR9C1}, GCG (glucagon) [NCBI Gene 2641] {aka GLP-1, GLP1, GLP2, GRPP}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, Slc16a7 (solute carrier family 16 member 7) [NCBI Gene 29735] {aka Mct2}, Slc1a3 (solute carrier family 1 member 3) [NCBI Gene 29483] {aka EAAT1, GLAST, GLAST-1, GluT-1}, HCAR2 (hydroxycarboxylic acid receptor 2) [NCBI Gene 338442] {aka GPR109A, HCA2, HM74a, HM74b, NIACR1, PUMAG}, ACAT1 (acetyl-CoA acetyltransferase 1) [NCBI Gene 38] {aka ACAT, MAT, T2, THIL}, Bdh1 (3-hydroxybutyrate dehydrogenase 1) [NCBI Gene 117099] {aka Bdh}, SLC16A7 (solute carrier family 16 member 7) [NCBI Gene 9194] {aka MCT2}, OXCT1 (3-oxoacid CoA-transferase 1) [NCBI Gene 5019] {aka OXCT, SCOT}, NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}, Mcat (malonyl CoA:ACP acyltransferase (mitochondrial)) [NCBI Gene 223722], Acat1 (acetyl-CoA acetyltransferase 1) [NCBI Gene 25014] {aka RATACAL}, SLC16A1 (solute carrier family 16 member 1) [NCBI Gene 6566] {aka HHF7, MCT, MCT1, MCT1D}, HMGCL (3-hydroxy-3-methylglutaryl-CoA lyase) [NCBI Gene 3155] {aka HL, HMGCL1}, Slc16a1 (solute carrier family 16 member 1) [NCBI Gene 25027] {aka MCT1, RATMCT1, RNMCT1}
- **Diseases:** traumatic brain injury (MESH:D000070642), AD (MESH:D000544), psychiatric disorders (MESH:D001523), Parkinson's disease (MESH:D010300), injury to (MESH:D014947), neurodegeneration (MESH:D019636), Lactation (MESH:D007775), inflammatory (MESH:D007249), neurological disorders (MESH:D009461), seizure (MESH:D012640), stroke (MESH:D020521), obese (MESH:D009765), Neurological Diseases (MESH:D020271), epilepsy (MESH:D004827), cognitive decline (MESH:D003072), migraine (MESH:D008881), ketosis (MESH:D007662), caloric restriction (MESH:D002313), multiple sclerosis (MESH:D009103), Glucose hypometabolism (MESH:D018149), dementia (MESH:D003704)
- **Chemicals:** TCA (MESH:D014233), carbon (MESH:D002244), triglycerides (MESH:D014280), 14C (MESH:C000615234), Ketone (MESH:D007659), lactose (MESH:D007785), lactate (MESH:D019344), BHB (MESH:D020155), pyruvate (MESH:D019289), 13C (MESH:C000615229), KBs (MESH:D007657), glycerol tri-acetate (MESH:D014215), glutamate (MESH:D018698), GABA (MESH:D005680), FFAs (MESH:D005230), acetyl-CoA (MESH:D000105), water (MESH:D014867), butanediol (MESH:D002072), fatty acid (MESH:D005227), carbohydrate (MESH:D002241), acetoacetate (MESH:C016635), 18F-FDG (MESH:D019788), oxaloacetate (MESH:D062907), acetoacetyl-CoA (MESH:C010667), Glycerol (MESH:D005990), octanoate (MESH:C031492), carnitine (MESH:D002331), decanoate (MESH:D003651), alpha-ketoglutarate (MESH:D007656), 3-hydroxy-3-methylglutaryl-CoA (MESH:C008047), 11C-Acac (-), glucose (MESH:D005947), dodecanoate (MESH:D007848), lysine (MESH:D008239), C8 (MESH:C037690), lipid (MESH:D008055), MCTs (MESH:C000709826), 11C (MESH:C000615233), ATP (MESH:D000255)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Rodentia (rodent, order) [taxon 9989], Cricetinae (hamsters, subfamily) [taxon 10026], Rattus norvegicus (brown rat, species) [taxon 10116], Gallus gallus (bantam, species) [taxon 9031], Bos taurus (bovine, species) [taxon 9913]
- **Cell lines:** /6 — Homo sapiens (Human), Tongue squamous cell carcinoma, Cancer cell line (CVCL_5985), HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030)

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12940000/full.md

---
Source: https://tomesphere.com/paper/PMC12940000